Wotton Paul K

Director at VCEL; President and CEO at ANTARES PHARMA, INC.

Sold, on record
$4.3M
Dollars the filings state
Form 4 sales
18
Latest May 11, 2026
Form 144 notices
5
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
10
Plan not stated
3
No plan
5
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. May 11, 2026Unusual

    VCEL

    Sold 34.7% of their holdings

    $327k10,000 shares at $32.74

    Filed May 13, 2026Form 4

  2. May 11, 2026Notice

    VCEL

    Filed a notice to sell 10,000 shares

    $327k10,000 shares

    Filed May 11, 2026Form 144

  3. Dec 3, 2025No plan

    VCEL

    Sold 16.3% of their holdings

    $190k5,000 shares at $37.90

    Filed Dec 4, 2025Form 4

  4. Dec 3, 2025Notice

    VCEL

    Filed a notice to sell 2,500 shares

    $95k2,500 shares

    Filed Dec 3, 2025Form 144

  5. Dec 2, 2025Notice

    VCEL

    Filed a notice to sell 2,500 shares

    $95k2,500 shares

    Filed Dec 2, 2025Form 144

  6. Dec 4, 2024No plan

    VCEL

    Sold 8.7% of their holdings

    $153k2,600 shares at $58.72

    Filed Dec 5, 2024Form 4

  7. Dec 4, 2024Notice

    VCEL

    Filed a notice to sell 2,600 shares

    $218k2,600 shares

    Filed Dec 4, 2024Form 144

  8. Dec 14, 2023No plan

    VCEL

    Sold 15.7% of their holdings

    $187k5,000 shares at $37.31

    Filed Dec 15, 2023Form 4

  9. Dec 14, 2023Notice

    VCEL

    Filed a notice to sell 5,000 shares

    $185k5,000 shares

    Filed Dec 14, 2023Form 144

  10. May 14, 2021Plan not stated

    VCEL

    Sold 15.8% of their holdings

    $253k5,000 shares at $50.52

    Filed May 17, 2021Form 4

10 of 23

Every transaction

Loading transactions…

Sales and notices (23)

Form 144 notices and Form 4 sales by Wotton Paul K
Source
May 11, 2026May 13, 2026VCELDirectorForm 4 sale10,000$327k34.7%UnusualSEC
May 11, 2026May 11, 2026VCELDirectorForm 144 notice10,000$327kNoticeSEC
Dec 3, 2025Dec 4, 2025VCELDirectorForm 4 sale5,000$190k16.3%No planSEC
Dec 3, 2025Dec 3, 2025VCELDirectorForm 144 notice2,500$95kNoticeSEC
Dec 2, 2025Dec 2, 2025VCELDirectorForm 144 notice2,500$95kNoticeSEC
Dec 4, 2024Dec 5, 2024VCELDirectorForm 4 sale2,600$153k8.7%No planSEC
Dec 4, 2024Dec 4, 2024VCELDirectorForm 144 notice2,600$218kNoticeSEC
Dec 14, 2023Dec 15, 2023VCELDirectorForm 4 sale5,000$187k15.7%No planSEC
Dec 14, 2023Dec 14, 2023VCELDirectorForm 144 notice5,000$185kNoticeSEC
May 14, 2021May 17, 2021VCELDirectorForm 4 sale5,000$253k15.8%Plan not statedSEC
May 12, 2021May 13, 2021VCELDirectorForm 4 sale15,648$781k33.1%UnusualSEC
Jan 2, 2019Jan 4, 2019VCELDirectorForm 4 sale22,500$379k100.0%UnusualSEC
Jun 18, 2018Jun 20, 2018VCELDirectorForm 4 sale30,000$362k100.0%UnusualSEC
Jan 15, 2014Jan 17, 2014ANTARES PHARMA, INC.President and CEOForm 4 sale22,900$117k3.1%Plan not statedSEC
Dec 9, 2013Dec 10, 2013ANTARES PHARMA, INC.President and CEOForm 4 sale64,100$256k8.3%Plan not statedSEC
Oct 1, 2013Oct 3, 2013ANTARES PHARMA, INC.President and CEOForm 4 sale35,000$147k4.7%Plan not statedSEC
Sep 3, 2013Sep 5, 2013ANTARES PHARMA, INC.President and CEOForm 4 sale35,000$154k4.7%Plan not statedSEC
Aug 1, 2013Aug 5, 2013ANTARES PHARMA, INC.President and CEOForm 4 sale35,000$155k4.7%Plan not statedSEC
Jul 1, 2013Jul 3, 2013ANTARES PHARMA, INC.President and CEOForm 4 sale35,000$145k4.7%Plan not statedSEC
Jun 3, 2013Jun 5, 2013ANTARES PHARMA, INC.President and CEOForm 4 sale125,000$501k15.0%UnusualSEC
May 6, 2013May 8, 2013ANTARES PHARMA, INC.President and CEOForm 4 sale10,000$40k1.9%Plan not statedSEC
Jan 8, 2013Jan 10, 2013ANTARES PHARMA, INC.President and CEOForm 4 sale25,000$100k4.4%Plan not statedSEC
Dec 4, 2012Dec 6, 2012ANTARES PHARMA, INC.President and CEOForm 4 sale25,000$100k4.4%Plan not statedSEC